Recognizing the right moment for a treatment-resistant depression referral
For many patients, depression care begins in primary care, OB-GYN, or outpatient psychiatry. Medications and psychotherapy help many people improve, but not everyone responds as expected.
When symptoms persist despite appropriate treatment, providers face a difficult question: Should we keep adjusting medications, or is it time to consider a different approach?
Understanding when to refer a patient for Transcranial Magnetic Stimulation (TMS) therapy can help patients access effective care sooner and reduce the long-term burden of untreated depression.
When Improvement Stalls: The Clinical Turning Point
A key signal for a treatment-resistant depression referral is limited response to one or more antidepressant trials.
Clinical guidelines generally suggest considering advanced treatments when:
- The patient has tried one or two antidepressants at adequate dose and duration
- Symptoms remain moderate to severe
- Functional impairment continues
At this stage, continuing multiple medication trials may offer diminishing returns, while prolonging patient distress. Early referral for TMS evaluation allows patients to explore evidence-based options without abandoning their current care relationship.
RELATED ARTICLE: Veteran Depression: Understanding the Hidden Battle and Where to Find Help
When Side Effects Become the Barrier
For some patients, the issue isn’t lack of efficacy, it’s poor tolerability.
Common scenarios include:
- Sedation, weight gain, or sexual side effects
- Medication interactions in medically complex patients
- Sensitivity to dose adjustments
- Difficulty maintaining adherence
Because TMS is a non-systemic treatment, it can be an appropriate option when medication side effects limit progress or quality of life.
When Patients Prefer to Avoid More Medications
Increasingly, patients express hesitation about adding or changing medications. This is especially common among:
- Individuals who have already tried multiple medications
- Patients concerned about long-term side effects
- Those seeking non-pharmacologic options
- Perinatal patients weighing fetal or breastfeeding exposure
Rather than viewing this as resistance to treatment, it can be an opportunity to discuss alternatives. A referral for TMS evaluation helps patients make informed decisions about their care.
When Medical or Reproductive Factors Complicate Treatment
Certain populations benefit from earlier consideration of advanced therapies, including:
- Perinatal or postpartum patients with moderate to severe depression
- Patients with chronic medical conditions requiring complex medication regimens
- Individuals with medication contraindications or high interaction risk
- Patients undergoing fertility treatment, menopause transition, or significant hormonal shifts
In these cases, minimizing systemic medication exposure while addressing mood symptoms may be clinically advantageous.
RELATED ARTICLE: How to Overcome Barriers to Depression Treatment
When Function Continues to Decline
Perhaps the most important signal is functional deterioration, even if symptoms appear only moderately improved.
Watch for:
- Missed work or declining performance
- Withdrawal from family or social roles
- Sleep disruption and persistent fatigue
- Increased healthcare utilization
- Reduced ability to manage daily responsibilities
When depression continues to limit a patient’s life despite treatment, it may be time to escalate care rather than continue incremental adjustments.
RELATED ARTICLE: Are You a Good Candidate for TMS Therapy? 7 Signs to Look For
Questions We’re Commonly Asked
Q. When should a patient be referred for TMS therapy?
A. Patients should be considered for TMS after inadequate response to one or two antidepressant trials, significant side effects, or ongoing functional impairment despite treatment.
Q. What qualifies as treatment-resistant depression?
A. Treatment-resistant depression typically refers to depression that has not improved after at least one or two adequate medication trials.
Q. Can TMS be used if a patient cannot tolerate medications?
A. Yes. TMS is a non-systemic treatment option that may be appropriate for patients who experience medication side effects or have medical contraindications.
Q. Is TMS appropriate for perinatal or medically complex patients?
A. TMS may be considered for patients where medication exposure is a concern or where medical complexity limits pharmacologic options. A clinical evaluation is required.
Q. Do patients need to stop their current medications before referral?
A. No. Most patients can continue their existing treatment plan while undergoing evaluation for TMS.
Earlier Access Can Change the Trajectory
Depression does not need to become chronic or disabling before advanced care is considered. Recognizing the right referral moment, especially after early treatment failure or functional decline, can shorten the path to recovery.
For providers managing complex or non-responding depression, a TMS evaluation offers an evidence-based next step, while preserving a collaborative, shared-care approach that keeps you central to your patient’s long-term mental health.
Contact Junction Brain Health today to see if your patient is a candidate for TMS therapy.